MedTrace Logo

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

NCT01243333 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-04-17

Study results available
· View outcomes & findings →

Summary

This clinical trial studies multi-tracer positron emission tomography in patients with solid tumors. Diagnostic procedures, such as multi-tracer positron emission tomography, may help measure a patient's response to treatment.

Conditions

  • Malignant Neoplasm

Interventions

RADIATION

[F-18]fluorodeoxyglucose

Undergo PET scans with \[F-18\]fluorodeoxyglucose

RADIATION

[F-18]fluorothymidine

Undergo PET scans with fluorine \[F-18\]fluorothymidine

PROCEDURE

Positron Emission Tomography

Undergo PET scans with 3 radiotracers (fludeoxyglucose F 18, fluorine F 18 fluorothymidine, and water O-15)

RADIATION

Water O-15

Undergo PET scans with water O-15 tracers

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Yap, PhD · Huntsman Cancer Institute/ University of Utah

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-02
Primary Completion
2015-12-12
Completion
2016-04-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01243333 on ClinicalTrials.gov